Prediction of psychosis: Setting the stage

British Journal of Psychiatry

Volumn 191, Issue SUPPL. 51, 2007, Pages

  Yung, Alison R ^a,b   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ORYGEN RESEARCH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; PLACEBO; RISPERIDONE;

ANXIETY DISORDER; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DISEASE COURSE; ETHICS; HUMAN; IRRITABILITY; MAJOR DEPRESSION; MOOD DISORDER; NEUROBIOLOGY; PREDICTION; PROGNOSIS; PSYCHOSIS; PSYCHOTHERAPY; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; SLEEP DISORDER; SUBSTANCE ABUSE; EDITORIAL; PSYCHOLOGICAL RATING SCALE;

HUMANS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS;

EID: 37249002721     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.191.51.s1     Document Type: Review

References (57)

1. Bebbington, P., Wilkins, S., Jones, P., et al (1993) Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 162, 72-79.
2. Bell, R. Q. (1992) Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370-381.
3. Brewer, W. J., Pantelis, C., Anderson, V., et al (2001) Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. American Journal of Psychiatry, 158, 107-115.
4. Brewer, W. J., Francey, S. M., Wood, S. J., et al (2005) Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. American Journal of Psychiatry, 162, 71-78.
5. Broome, M. R., Woolley, J. B., Tabraham, P., et al (2005) What causes the onset of psychosis? Schizophrenia Research, 79, 23-34.
6. Cornblatt, B., Lencz, T., Correll, C., et al (2002) Treating the prodrome: naturalistic findings from the RAP program. Acta Psychiatrica Scandinavica, 106, 44.
7. Escher, S., Romme, M., Buiks, A., et al (2002) Formation of delusional ideation in adolescents hearing voices: A prospective study. American Journal of Medical Genetics, 114, 913-920.
8. Fava, G. A. & Kellner, R. (1993) Staging: a neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 87, 225-230.
9. Freeman, D. & Garety, P. A. (2003) Connecting neurosis and psychosis: The direct influence of emotion on delusions and hallucinations. Behavioural Research Therapy, 41, 923-947.
10. Garner, B., Pariante, C. M., Wood, S. J., et al (2005) Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry, 58, 417-423.
11. Goldman-Rakic, P. S. (1994) Working memory in schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences, 6, 348-357.
12. Green, M. F. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321-330.
13. Hafner, H., Maurer, K., Loffler, W., et al (1994) The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. British Journal of Psychiatry, 164 (suppl. 23), 29-38.
14. Hafner, H., Maurer, K., Trendler, G., et al (2005) Schizophrenia and depression: Challenging the paradigm of two separate diseases. A controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77, 11-24.
15. Hanssen, M., Krabbendam, L., de Graaf, R., et al (2005) Role of distress in delusion formation. British Journal of Psychiatry, 187, s55-s58.
16. Haroun, N., Dunn, L., Haroun, A., et al (2006) Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophrenia Bulletin, 32, 166-178.
17. Hirsch, S., Bowen, J., Emani, J., et al (1996) A one year prospective study of the effect of life events and medication in the aetiology of schizophrenic relapse. British Journal of Psychiatry, 168, 49-56.
18. Johns, L. C., Cannon, M., Singleton, N., et al (2004) Prevalence and correlates of self-reported psychotic symptoms in the British population. British Journal of Psychiatry, 185, 298-305.
19. Johnstone, E. C., Ebmeier, K. P., Miller, P., et al (2005) Predicting schizophrenia: Findings from the Edinburgh High-Risk Study. British Journal of Psychiatry, 186, 18-25.
20. Kaneko, M., Yokoyama, F., Hoshino, Y., et al (1992) Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features. Neuropsychobiology, 25, 1-7.
21. Klosterkotter, J., Schultze-Lutter, F., Gross, G., et al (1997) Early self-experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8-year average follow-up prospective study. Acta Psychiatrica Scandinavica, 95, 396-404.
22. Klosterkotter, J., Hellmich, M., Steinmeyer, E. M., et al (2001) Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158-164.
23. Klosterkotter, J., Birchwood, M., Linszen, D., et al (2005) Overview on the recruitment, sample characteristics, and distribution of inclusion criteria of the European Prediction of Psychosis Study (EPOS). European Psychiatry, 20, 48.
24. Krabbendam, L., Myin-Germeys, I., Hanssen, M., et al (2005) Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. British Journal of Clinical Psychology, 44, 113-125.
25. Lencz, T., Smith, C. W., Auther, A., et al (2004) Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophrenia Research, 68, 37-48.
26. Linszen, D. H., Dingemans, P. M. & Lenior, M. E. (1994) Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry, 51, 273-279.
27. Malla, A. K., & Norman, R. M. G. (1992) Relationship of life events and daily stressors to symptomatology in schizophrenia. Journal of Nervous and Mental Disease, 180, 664-667.
28. Mason, O., Startup, M., Halpin, S., et al (2004) State and trait predictors of transition to first episode psychosis among individuals with at risk mental states. Schizophrenia Research, 71, 227-237.
29. McGlashan, T. H., Zipursky, R. B., Perkins, D., et al (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. American Journal of Psychiatry, 163, 790-799.
30. McGorry, P. D., Yung, A. & Phillips, L. (2001) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophrenia Research, 51, 17-29
31. McGorry, P. D., Yung, A. R., Phillips, L. J., et al (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
32. McGorry, P. D., Killackey, E., Lambert, M., et al (2005) Australia and New Zealand clinical practice guidelines for the treatment of schizophrenia. Australia and New Zealand Journal of Psychiatry, 39, 1-30.
33. McGorry, P. D., Hickie, I. B., Yung, A. R., et al (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Australia and New Zealand Journal of Psychiatry 40, 616-622.
34. Miller, P., Lawrie, S. M., Hodges, A., et al (2001) Genetic liability, illicit drug use, life stress and psychotic symptoms: Preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 36, 338-342.
35. Morrison, A. P., French, P., Walford, L., et al (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. British Journal of Psychiatry, 185, 291-297.
36. Mrazek, P. J. & Haggerty, R. J. (eds) (1994) Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention research. National Academy Press.
37. Myin-Germeys, I., van Os, J., Schwartz, J. E., et al (2001) Emotional reactivity to daily life stress in psychosis. Archives of General Psychiatry, 58, 1137-1144.
38. Olsen, K. A. & Rosenbaum, B. (2006) Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatrica Scandinavica, 113, 247-272.
39. Pantelis, C., Velakoulis, D., McGorry, P. D., et al (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361, 281-288.
40. Pariante, C. M., Vassilopoulou, K., Velakoulis, D., et al (2004) Pituitary volume in psychosis. British Journal of Psychiatry, 185, 5-10.
41. Phillips, L. J., Curry, C., Yung, A. R., et al (2002a) Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Australia and New Zealand Journal of Psychiatry, 36, 800-806.
42. Phillips, L. J., Velakoulis, D., Pantelis, C., et al (2002b) Non-reduction in hippocampal volume is associated with risk for psychosis. Schizophrenia Research, 58, 145-158.
43. Thompson, K., Berger, G., Phillips, L., et al (2007) HPA axis functioning associated with transition to psychosis: combined DEX/CRH test. Journal of Psychiatric Research, 41, 446-450.
44. Thornicroft, G. (1990) Cannabis and psychosis. Is there epidemiological evidence for an association? British Journal of Psychiatry, 157, 25-33.
45. Tien, A. Y. (1991) Distributions of hallucinations in the population. Social Psychiatry and Psychiatric Epidemiology, 26, 287-292.
46. van Os, J., Hanssen, M., Bijl, R. V., et al (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: An urban-rural comparison. Archives of General Psychiatry, 58, 663-668.
47. Velakoulis, D., Pantelis, C., McGorry, P. D., et al (1999) Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high resolution magnetic resonance imaging study. Archives of General Psychiatry, 56, 133-141.
48. Velakoulis, D., Wood, S. J., Wong, M. T. H., et al (2006) Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Archives of General Psychiatry, 63, 139-149.
49. Yung, A. R. (2006) Identification of the population. In Working with People at High Risk for Developing Psychosis: A Treatment Handbook (eds A. P. Morrison, J. Addington & S. M. Francey), pp. 7-23. John Wiley.
50. Yung, A. R. & McGorry, P. D. (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin, 22, 353-370.
51. Yung, A. R., McGorry, P. D., McFarlane, C. A., et al (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22, 283-303.
52. Yung, A. R., Phillips, L. J., Yuen, H. P., et al (2003) Psychosis prediction: 12-month follow up of a high-risk ('prodromal') group. Schizophrenia Research, 60, 21-32.
53. Yung, A. R., Phillips, L. J., Yuen, H. P., et al (2004) Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophrenia Research, 67, 131-142.
54. Yung, A. R., Yuen, H. P., McGorry, P. D., et al (2005) Mapping the onset of psychosis - the Comprehensive Assessment of At Risk Mental States (CAARMS). Australia and New Zealand Journal of Psychiatry, 39, 964-971.
55. Yung, A. R., Buckby, J. A., Cotton, S. M., et al (2006) Psychotic-like experiences in non-psychotic help-seekers: associations with distress, depression and disability. Schizophrenia Bulletin, 32, 352-359.
56. Yung, A. R., Stanford, C., Cosgrave, E., et al (2006) Testing the ultra high risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophrenia Research, 84, 57-66.
57. Zammit, S. (2002) Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. British Medical Journal, 325, 1199-1204.